Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
2000 2
2001 1
2005 1
2006 1
2010 1
2011 1
2012 1
2015 4
2016 1
2020 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac Metastasis of Sacral Chordoma.
Stefàno PL, Barletta G, Andrei V, Cerillo AG, Nesi G, Pilato G, Pradella S, Santi R, Del Bene MR. Stefàno PL, et al. Ann Thorac Surg. 2021 May;111(5):e319-e321. doi: 10.1016/j.athoracsur.2020.07.093. Epub 2020 Oct 29. Ann Thorac Surg. 2021. PMID: 33129773
Despite its slow growth, it is locally aggressive and has a poor long-term prognosis. Surgery is the mainstay treatment. Although cardiac metastases are very rare, the heart is frequently involved in systemic neoplastic diseases. ...
Despite its slow growth, it is locally aggressive and has a poor long-term prognosis. Surgery is the mainstay treatment. Although car …
Activity of pemetrexed in pre-clinical chordoma models and humans.
Kesari S, Wang F, Juarez T, Ashili S, Patro CPK, Carrillo J, Nguyen M, Truong J, Levy J, Sommer J, Freed DM, Xiu J, Takasumi Y, Bouffet E, Gill JM. Kesari S, et al. Sci Rep. 2023 May 5;13(1):7317. doi: 10.1038/s41598-023-34404-4. Sci Rep. 2023. PMID: 37147496 Free PMC article.
Eighty-four percent of chordoma samples had loss of TS expression which may predict response to anti-folates. Pemetrexed suppresses tumor growth by inhibiting enzymes involved in folate metabolism, resulting in decreased availability of thymidine which is necessary for DNA …
Eighty-four percent of chordoma samples had loss of TS expression which may predict response to anti-folates. Pemetrexed suppresses t …
Metastatic chordoma with pancreatic disease and response to imatinib.
Klejnow EV, Hoban K, Nixon I, Elswood TR. Klejnow EV, et al. BMJ Case Rep. 2022 Jan 19;15(1):e240062. doi: 10.1136/bcr-2020-240062. BMJ Case Rep. 2022. PMID: 35046072 Free PMC article.
She had initially been managed surgically with a cervical vertebrectomy and a course of proton beam therapy. Although there had been a degree of residual tissue, her disease remained stable radiologically and clinically. ...
She had initially been managed surgically with a cervical vertebrectomy and a course of proton beam therapy. Although there had been …
Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.
Lebellec L, Aubert S, Zaïri F, Ryckewaert T, Chauffert B, Penel N. Lebellec L, et al. Crit Rev Oncol Hematol. 2015 Jul;95(1):125-31. doi: 10.1016/j.critrevonc.2015.01.010. Epub 2015 Jan 30. Crit Rev Oncol Hematol. 2015. PMID: 25682222 Review.
A systematic analysis of these publications shows that the best objective response with targeted therapies was stabilization in 52 to 69% of chordomas. Given the indolent course of advanced chordoma and because of the absence of randomized trial, the level of evidence to t …
A systematic analysis of these publications shows that the best objective response with targeted therapies was stabilization in 52 to 69% of …
Imaging characteristics of metastatic chordoma.
Kishimoto R, Omatsu T, Hasegawa A, Imai R, Kandatsu S, Kamada T. Kishimoto R, et al. Jpn J Radiol. 2012 Jul;30(6):509-16. doi: 10.1007/s11604-012-0086-3. Epub 2012 May 18. Jpn J Radiol. 2012. PMID: 22592289
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA, Raza SM, Amini M, Seaman S, Rubino F, Snyder R, Patel S, DeMonte F, Conley AP. Banu MA, et al. Neurosurg Focus. 2024 May;56(5):E15. doi: 10.3171/2024.2.FOCUS2416. Neurosurg Focus. 2024. PMID: 38691867 Review.
Furthermore, several molecular biomarkers have been recently uncovered as potential predictors of the response to specific molecular therapeutics. The authors describe the recently discovered role of 1p36 and 9p21 deletions as biomarkers capable of guiding drug selection. …
Furthermore, several molecular biomarkers have been recently uncovered as potential predictors of the response to specific molecular …
Imatinib in advanced chordoma: A retrospective case series analysis.
Hindi N, Casali PG, Morosi C, Messina A, Palassini E, Pilotti S, Tamborini E, Radaelli S, Gronchi A, Stacchiotti S. Hindi N, et al. Eur J Cancer. 2015 Nov;51(17):2609-14. doi: 10.1016/j.ejca.2015.07.038. Epub 2015 Aug 14. Eur J Cancer. 2015. PMID: 26283036
Parachordoma: a case report.
Separović R, Glumbić I, Pigac B, Separović V, Kruslin B. Separović R, et al. Tumori. 2001 May-Jun;87(3):207-10. doi: 10.1177/030089160108700318. Tumori. 2001. PMID: 11504379
It should be distinguished from metastatic chordoma and extraskeletal myxoid chondrosarcoma because of its different treatment and prognosis. In this paper we report one case of parachordoma in a 20-year-old female patient. ...
It should be distinguished from metastatic chordoma and extraskeletal myxoid chondrosarcoma because of its different treatment and progno …
18 results